Researchers show for the first time that engineered human plasma B cells can be used to treat a disease—specifically leukemia—in a humanized animal model. The results mark a key step in the ...
Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and ...
News-Medical.Net on MSN
Researchers identify key differences between two subtypes of chronic lymphocytic leukemia
Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and ...
Researchers headed by a team at Seattle Children’s Research Institute have shown for the first time that engineered human plasma B cells can be used to treat a disease—more specifically leukemia—in a ...
Scientists at the University of Washington have engineered human plasma B cells modified to express long-lasting bispecific antibodies that could be used to treat leukemia without requiring continuous ...
Cell culture materials impact a target cell’s ability to proliferate and function as planned. These materials offer precise mechanical and chemical cues that decide a cell's morphology and ...
Epstein-Barr virus (EBV) infection is a recognized risk factor that is now regarded as a prerequisite for the development of multiple sclerosis (MS). Recently, significant advances have been made in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback